Rainer M. Lüönd

511 total citations
8 papers, 249 citations indexed

About

Rainer M. Lüönd is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Rainer M. Lüönd has authored 8 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Organic Chemistry. Recurrent topics in Rainer M. Lüönd's work include Porphyrin Metabolism and Disorders (3 papers), Alzheimer's disease research and treatments (2 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). Rainer M. Lüönd is often cited by papers focused on Porphyrin Metabolism and Disorders (3 papers), Alzheimer's disease research and treatments (2 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). Rainer M. Lüönd collaborates with scholars based in Switzerland, United Kingdom and Austria. Rainer M. Lüönd's co-authors include R. Ortmann, Mauro Zurini, Martin F. Bachmann, M. Staufenbiel, Laura H. Jacobson, S. A. Danner, Karl‐Heinz Wiederhold, Anis K. Mir, Gary T. Jennings and Pascal Frey and has published in prestigious journals such as Journal of Neuroscience, Biochemical Pharmacology and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Rainer M. Lüönd

8 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer M. Lüönd Switzerland 6 126 73 57 57 52 8 249
Valérie Giriens Switzerland 5 213 1.7× 97 1.3× 93 1.6× 78 1.4× 77 1.5× 7 308
Xuejian Feng China 8 95 0.8× 134 1.8× 21 0.4× 39 0.7× 14 0.3× 12 286
Adeola Shobo South Africa 13 95 0.8× 106 1.5× 43 0.8× 32 0.6× 13 0.3× 24 355
Veronica Craik United States 7 62 0.5× 168 2.3× 25 0.4× 25 0.4× 60 1.2× 9 286
Karen Beltz Switzerland 7 120 1.0× 78 1.1× 63 1.1× 9 0.2× 74 1.4× 10 242
Zhijian Hu United States 9 94 0.7× 147 2.0× 40 0.7× 34 0.6× 10 0.2× 32 340
Jason Martin United States 5 243 1.9× 236 3.2× 53 0.9× 16 0.3× 73 1.4× 6 355
Mihaela Oana Romanitan Sweden 7 36 0.3× 68 0.9× 11 0.2× 74 1.3× 18 0.3× 20 239
Saketh Chemuru United States 7 236 1.9× 240 3.3× 22 0.4× 19 0.3× 39 0.8× 9 353
Chen-Wei Wang China 8 77 0.6× 63 0.9× 41 0.7× 14 0.2× 25 0.5× 13 220

Countries citing papers authored by Rainer M. Lüönd

Since Specialization
Citations

This map shows the geographic impact of Rainer M. Lüönd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer M. Lüönd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer M. Lüönd more than expected).

Fields of papers citing papers by Rainer M. Lüönd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer M. Lüönd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer M. Lüönd. The network helps show where Rainer M. Lüönd may publish in the future.

Co-authorship network of co-authors of Rainer M. Lüönd

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer M. Lüönd. A scholar is included among the top collaborators of Rainer M. Lüönd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer M. Lüönd. Rainer M. Lüönd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wießner, Christoph, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2011). The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects. Journal of Neuroscience. 31(25). 9323–9331. 149 indexed citations
2.
Staufenbiel, Matthias, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2006). O1–06–01: Immunization with Aβ1–6 coupled to the virus–like particle Qβ (CAD106) efficiently removes β–amyloid without inducing Aβ–reactive T–cells. Alzheimer s & Dementia. 2(3S_Part_1). 2 indexed citations
3.
Lüönd, Rainer M., et al.. (2000). Inhibition of Escherichia coli porphobilinogen synthase using analogs of postulated intermediates. Chemistry & Biology. 7(3). 185–196. 23 indexed citations
4.
Lüönd, Rainer M., et al.. (1998). Inhibitors of Glutathione Reductase as Potential Antimalarial Drugs Kinetic Cooperativity and Effect of Dimethyl Sulphoxide on Inhibition Kinetics. Journal of enzyme inhibition. 13(5). 327–345. 17 indexed citations
5.
Lüönd, Rainer M. & Reinhard Neier. (1996). On the formation of the mixed pyrrole catalysed by porphobilinogen synthase from Rhodobacter spheroides. Biochimica et Biophysica Acta (BBA) - General Subjects. 1289(1). 83–86. 4 indexed citations
6.
Lüönd, Rainer M., et al.. (1993). A direct link between LY83583, a selective repressor of cyclic GMP formation, and glutathione metabolism. Biochemical Pharmacology. 45(12). 2547–2549. 17 indexed citations
7.
Lüönd, Rainer M. & Reinhard Neier. (1991). Michael Reactions of α‐Unsubstituted Trisubstituted 1H‐Pyrroles. Helvetica Chimica Acta. 74(1). 91–102. 8 indexed citations
8.
Lüönd, Rainer M., et al.. (1989). Cyclometalated Compounds of Platinum(II) with two different C, N‐aromatic ligands. Helvetica Chimica Acta. 72(2). 377–382. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026